Mirum Pharmaceuticals, Inc. financial data

Symbol
MIRM on Nasdaq
Industry
Pharmaceutical Preparations
Location
989 East Hillsdale Boulevard, Suite 300, Foster City, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 404 % -6.34%
Quick Ratio 22.8 % +84.1%
Debt-to-equity 166 % -8.5%
Return On Equity -44.5 % +66.5%
Return On Assets -16.7 % +64.5%
Operating Margin -41 % +59.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 47.7M shares +24.6%
Common Stock, Shares, Outstanding 47.6M shares +24.5%
Entity Public Float 830M USD +36.3%
Common Stock, Value, Issued 5K USD +25%
Weighted Average Number of Shares Outstanding, Basic 47.2M shares +24%
Weighted Average Number of Shares Outstanding, Diluted 47.2M shares +24%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 264M USD +128%
Operating Income (Loss) -108M USD +8.47%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -107M USD +38.8%
Income Tax Expense (Benefit) 1.73M USD +101%
Net Income (Loss) Attributable to Parent -109M USD +38.1%
Earnings Per Share, Basic -2.32 USD/shares +51.1%
Earnings Per Share, Diluted -2.32 USD/shares +51.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 233M USD -21.5%
Accounts Receivable, after Allowance for Credit Loss, Current 60.4M USD +71.1%
Inventory, Net 20.4M USD +140%
Assets, Current 368M USD -4.09%
Property, Plant and Equipment, Net 1.1M USD +27.1%
Operating Lease, Right-of-Use Asset 8.76M USD +443%
Intangible Assets, Net (Excluding Goodwill) 262M USD +364%
Other Assets, Noncurrent 3.97M USD +244%
Assets 661M USD +49%
Accounts Payable, Current 9.84M USD -31.9%
Employee-related Liabilities, Current 16.8M USD +53.1%
Accrued Liabilities, Current 101M USD +137%
Liabilities, Current 112M USD +93%
Operating Lease, Liability, Noncurrent 8.24M USD +614%
Other Liabilities, Noncurrent 3.97M USD +39620%
Liabilities 432M USD +18.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -477K USD -728%
Retained Earnings (Accumulated Deficit) -606M USD -22%
Stockholders' Equity Attributable to Parent 229M USD +191%
Liabilities and Equity 661M USD +49%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 15.2M USD
Net Cash Provided by (Used in) Financing Activities 1.21M USD -90.7%
Net Cash Provided by (Used in) Investing Activities 27M USD -26%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 47.6M shares +24.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 16.5M USD -22.9%
Deferred Tax Assets, Valuation Allowance 143M USD +39%
Deferred Tax Assets, Gross 143M USD +38.7%
Operating Lease, Liability 9.32M USD +320%
Payments to Acquire Property, Plant, and Equipment 13K USD -68.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -110M USD +37.7%
Lessee, Operating Lease, Liability, to be Paid 11.3M USD +365%
Operating Lease, Liability, Current 1.07M USD +0.75%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.26M USD +532%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.21M USD +85.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure -12.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.98M USD +827%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.32M USD +1936%
Deferred Tax Assets, Operating Loss Carryforwards 40.5M USD +17.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 10.5M USD +13%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.33M USD +1944%
Operating Lease, Payments 289K USD +10.3%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 19.1M USD +306%
Depreciation, Depletion and Amortization 5.66M USD +324%
Share-based Payment Arrangement, Expense 41.4M USD +34.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%